Wells Fargo’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50
| Closed | -$380 | – | 6634 |
|
|
2024
Q1 | $380 | Buy |
50
+7
| +16% | +$53 | ﹤0.01% | 5953 |
|
|
2023
Q4 | $359 | Buy |
43
+21
| +95% | +$175 | ﹤0.01% | 6013 |
|
|
2023
Q3 | $186 | Buy |
22
+7
| +47% | +$59 | ﹤0.01% | 6229 |
|
|
2023
Q2 | $143 | Hold |
15
| – | – | ﹤0.01% | 6480 |
|
|
2023
Q1 | $86 | Hold |
15
| – | – | ﹤0.01% | 6644 |
|
|
2022
Q4 | $118 | Buy |
15
+1
| +7% | +$8 | ﹤0.01% | 6429 |
|
|
2022
Q3 | $0 | Sell |
14
-4
| -22% | – | ﹤0.01% | 6480 |
|
|
2022
Q2 | $0 | Sell |
18
-478
| -96% | – | ﹤0.01% | 6647 |
|
|
2022
Q1 | $10K | Sell |
496
-1,164
| -70% | -$23.5K | ﹤0.01% | 5907 |
|
|
2021
Q4 | $48K | Buy |
1,660
+1,642
| +9,122% | +$47.5K | ﹤0.01% | 5527 |
|
|
2021
Q3 | $2K | Buy |
18
+8
| +80% | +$889 | ﹤0.01% | 6229 |
|
|
2021
Q2 | $1K | Sell |
10
-181
| -95% | -$18.1K | ﹤0.01% | 6308 |
|
|
2021
Q1 | $35K | Buy |
+191
| New | +$35K | ﹤0.01% | 5625 |
|